| abstract |
The present invention relates to compounds that inhibit, regulate and / or modulate the tyrosine kinase signal transduction, compositions containing these compounds, and methods for using them to treat diseases and conditions dependent on tyrosine kinase, such as angiogenesis, cancer, tumor growth, atherosclerosis, age-related macular degeneration, diabetic retinopathy, inflammatory diseases and the like in mammals. |